{"name":"Kira Pharmacenticals (US), LLC.","slug":"kira-pharmacenticals-us-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KP104","genericName":"KP104","slug":"kp104","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"KP104","genericName":"KP104","slug":"kp104","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2024-12-10","type":"regulatory","source":"PR Newswire","summary":"Kira Pharmaceuticals Presents Updated Data of Phase 2 Study of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH) at American Society of Hematology (ASH) 2024 Demonstrating Long-Term Safety and Effica","headline":"Kira Pharmaceuticals Presents Updated Data of Phase 2 Study of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH) at Ame","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"PR Newswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOcmt4VWU2dlRCbkg4Vjd5TjcxdXRTLXVuM1RNM2JsR1pTNl9mYVIwUWRxaTlOdFFfMEgtRFN1MmdDTjRHcnJTay1Qd0VVZGYzelJQLUlEaVR2RmhDT3N3SU1BSnJZWWlOc3pZdG50djhUYUNBQ29RNW1hNFhqa0t5RklUQ1FwdXRSZTFUcjhRV2FPTUJXZmc4XzhkYmtLbTY0TUp2OHZkZFRBOG4xZEFsVnRNdWEtX0xua2FRczdNYXpPQ0M3VG5Pdm9IblF3c2hjSUstdG9yVzVLSjNvOWl0SWRwem9Lc245eWc?oc=5","date":"2022-08-02","type":"pipeline","source":"PR Newswire Asia","summary":"Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations - PR Newswire Asia","headline":"Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPUkNKYk5lS2tmNVZaWXJjQTFGN1k1Z2F2SFdtdUN5VXZOTGUxdUhOYXNPT2ZxeGRla2NILTRYa0dyZlFmejFNelpGLXpUc0N1M2lva04zZTY3bkdTejhLaDY3a3ZsOHVNaVZ1LVVNLVQxamhlbHk1WmZqaFdYZEF3X0t5bjZxdTlkWGJMQ3V4dEpHVzhRUDlFMlhlOXl4UDZhX2xoTzNJODg1aWFNLUR5OWFZQVhud3pJMUVUbXNEcXdhSmNDVm1UaVVfV2lBenBHMW00bTExV0llVGVvekpvSXoxZ2UtSWV5OW5OQ01GaXZRRm54WmV5a0pGdkp4bXBpVThUa28yT1ZJZUZFOVNDT28xS1FMR1Y4YWtsbmxKSTBQTHRtRFR5RGJDdldDZw?oc=5","date":"2021-01-07","type":"pipeline","source":"PR Newswire","summary":"Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies - PR Newswire","headline":"Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQVDhlQTBjT1FrZkp2RnpLRGNOOFUtNzkzMk9HSW9QWmxYZWVTckNBaFhmVG4yUUd1WURmeTR1SVNTcDh1ZjUwZUdQeFJDV1hyV094S2h2Sk80TmZpbjZXcTQ3ZkZfMDVobEJzcWk5SV9KQmRSQ25tX2RCS0ZWZEoyUXZRaHo0ZU05clFkVnBDU1lEUm9YRl9HeGZ0Zmh1SGd5YmVpa2k0bDk?oc=5","date":"2020-11-12","type":"pipeline","source":"Fierce Biotech","summary":"Kira Pharma launches with $46M to bring complement drugs to more diseases - Fierce Biotech","headline":"Kira Pharma launches with $46M to bring complement drugs to more diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNc1k4Q2w4SzRVNFM5UVZhSklKMXJQOWRWSlhUemFuWFBsX21QUXRIM2xzbHowM19iSXFoNFlXLXIwM20tenpsQVhpdE1QWDN4cVQ1b3pGV3Yxb1NJRUNHUHFtek5UZlNsNDRfekhRVFFIYUQ1OVNSWEJoak5ySXY2TkVHSVJ2ZFR1RkhMRzJ0YnJjbGRwX21URFNkMHhyOUJIRjlTczJBQ3BBN1hhbk4xaGgwY2hnVTlIclJ1WVFWVTFkTGxNZTN2N0w1UXgzVDBLUnZKZmRuNGZURDB2MjVPZVpn?oc=5","date":"2020-11-12","type":"pipeline","source":"PR Newswire","summary":"Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases - PR Newswire","headline":"Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOM3pnSnI4VXROMkhBX0pkRGdmLTllRFBqTzBDakhSSGxKVHBkNUtvTlV1aDZyZUlKUjZDLWhaTzRuVllDT3ZJWmVGdkl2Y2dOX2g3M2VFNXY1UlpzcnBpNDJMZFlydjJaTWxBZlhrUkJEd0wwZFI3SURmN1BTd0doRE8yZVFPajVmQkpmOHZwdnlvWVZuWG5ZU2tPRGUteHB3NThvcEgyTG5TOFcyRVYwWTQ0OHJTdw?oc=5","date":"2019-01-21","type":"patent","source":"Chemistry World","summary":"Patent-busting AI tool navigates around protected drug pathways - Chemistry World","headline":"Patent-busting AI tool navigates around protected drug pathways","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}